GeneDx Holdings Corp (NASDAQ: WGS) is 223.85% higher on its value in year-to-date trading and has touched a low of $24.91 and a high of $117.75 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The WGS stock was last observed hovering at around $90.90 in the last trading session, with the day’s loss setting it -89.75%.
Currently trading at $1.15M, the stock is 23.78% and 16.79% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.54 million and changing 1544284% at the moment leaves the stock 19.22% off its SMA200. WGS registered 15.70% gain for a year compared to 6-month loss of 18.10%. The firm has a 50-day simple moving average (SMA 50) of $76.1433 and a 200-day simple moving average (SMA200) of $74.59073.
The stock witnessed a 24.20% gain in the last 1 month and extending the period to 3 months gives it a -11.59%, and is 38.87% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.85% over the week and 5.70% over the month.
GeneDx Holdings Corp (WGS) has around 1000 employees, a market worth around $2.54B and $330.14M in sales. Fwd P/E is 43.69. Profit margin for the company is -11.68%. Distance from 52-week low is 257.01% and -24.48% from its 52-week high. The company has generated returns on investments over the last 12 months (-10.45%).
The EPS is expected to grow by 321.86% this year
303.0 institutions hold shares in GeneDx Holdings Corp (WGS), with institutional investors hold 118.07% of the company’s shares. The shares outstanding are 28.53M, and float is at 24.95M with Short Float at 14.57%. Institutions hold 103.24% of the Float.
The top institutional shareholder in the company is CASDIN CAPITAL, LLC with over 3.53 million shares valued at $92.18 million. The investor’s holdings represent 13.2482 of the WGS Shares outstanding. As of 2024-06-30, the second largest holder is CORVEX MANAGEMENT LP with 2.47 million shares valued at $64.66 million to account for 9.2937 of the shares outstanding. The other top investors are ORACLE INVESTMENT MANAGEMENT INC which holds 1.11 million shares representing 4.1542 and valued at over $28.9 million, while GOLDMAN SACHS GROUP INC holds 3.9517 of the shares totaling 1.05 million with a market value of $27.5 million.
GeneDx Holdings Corp (WGS) Insider Activity
The most recent transaction is an insider sale by Stueland Katherine, the company’s Chief Executive Officer. SEC filings show that Stueland Katherine sold 10,501 shares of the company’s common stock on Jun 16 ’25 at a price of $64.77 per share for a total of $0.68 million. Following the sale, the insider now owns 14597.0 shares.
GeneDx Holdings Corp disclosed in a document filed with the SEC on Jun 16 ’25 that Feeley Kevin (CHIEF FINANCIAL OFFICER) sold a total of 3,729 shares of the company’s common stock. The trade occurred on Jun 16 ’25 and was made at $64.77 per share for $0.24 million. Following the transaction, the insider now directly holds 8769.0 shares of the WGS stock.
Still, SEC filings show that on Jun 09 ’25, Feeley Kevin (CHIEF FINANCIAL OFFICER) disposed off 1,266 shares at an average price of $72.55 for $91848.0. The insider now directly holds 5,301 shares of GeneDx Holdings Corp (WGS).
